ꢁ
22ꢁ
Balakishan et al.: Lewis acid / Base-free Strategy
(ESI): 241 (M+H). HR-MS: Calculated for C14H12N2S (M+H) = Research funding:ꢀFinancial support was provided by
241.0794. Found = 241.0793.
the DST, New Delhi, India (Grant No: SR/S1/OC-08/2011).
4-Methyl-2-(phenylthio)thiazole (3j) (Table 2, Entry
1
7): Yellow liquid, yield 175 mg (78%). H-NMR (500MHz, Conflict of interest:ꢀAuthors state no conflict of interest.
CDCl3): δ 7.58-7.60 (m, 2H), 7.38-7.40 (m, 2H), 7.21 (s, 1H),
6.70 (s,1H), 2.41 (s, 3H). 13C-NMR (75MHz, CDCl3): δ 164.7, Data availability statement:ꢀAll data generated or ana-
153.5 133.5, 132.0, 129.6, 129.3, 115.0, 17.1. IR (neat): 3019.7, lyzed during this study are included in this published
1710, 1661.4, 1628, 1549, 1515.3, 1214.8, 742, 667, 627 cm-1. article and its supplementary information files.
MS (ESI): 208 (M+H). HR-MS: Calculated for C10H9NS2
(M+H) = 208.0249. Found = 208.0250.
2-Phenyl-5-(phenylthio)-1, 3, 4-oxadiazole (3k)
References
(Table 2, Entry 8): Yellow liquid, yield 140 mg (80%).
1H-NMR (500MHz, CDCl3): δ 7.97-7.90 (m, 2H), 7.69-7.60 (m,
[1] Jain VK. Chapter 1: An Overview of Organoselenium Chemistry:
2H), 7.50-7.40 (m, 6H). 13C-NMR (75MHz, CDCl3): δ 166.3,
From Fundamentals to Synthesis. In: Jain VK, Priyadarsini KI,
editors. Organoselenium Compounds in Biology and Medicine.
162.8, 133.6, 131.7, 129.7, 128.9, 126.7, 123.4. IR (neat): 3019,
Synthesis, Biological and Therapeutic Treatments. Royal
1710, 1661, 1628, 1549, 1515, 1214, 742, 667, 627 cm-1. MS (ESI):
Chemical Society; 2017. p. 1–33.
255 (M+H). HR-MS: Calculated for C14H10N2OS (M+H) =
255.9684. Found = 255.9693.
[2] Iwaoka M. Antioxidant Organoselenium Molecules. In: Santi C,
editor. Organoselenium Chemistry Between Synthesis and
Biochemistry. Bentham Science Publishers; p. 361-78.
[3] Sies H. Ebselen, a selenoorganic compound as glutathione
peroxidase mimic. Free Radic Biol Med. 1993 Mar;14(3):313–23.
[4] Nascimento V, Alberto EE, Tondo DW, Dambrowski D, Detty MR,
Nome F, et al. GPx-Like activity of selenides and selenoxides:
experimental evidence for the involvement of hydroxy
perhydroxy selenane as the active species. J Am Chem Soc.
2012 Jan;134(1):138–41.
2-((Phenylselanyl)thio)benzo(d)thiazole
(5a)
(Table 3, Entry 1): Yellow liquid, yield 155 mg (77%).
1H-NMR (500MHz, CDCl3): δ 7.90 (d, 1H, J = 8.2 Hz), 7.70 (d,
1H, J = 7.6 Hz), 7.50-7.61 (m, 2H), 7.24-7.28 (m,5H). 13C-NMR
(75MHz, CDCl3): δ 131.4, 129.8, 129.5, 129.1, 128.9, 127.6, 126.5,
125.2, 122.5, 121.2. IR (neat): 2956, 2918, 2850, 1727, 1462,
1426.3, 1377.8, 1265, 1123, 1077, 1003, 972, 909, 727, 687 cm-1.
MS (ESI): 323 (M+H). HR-MS: Calculated for C13H9NSeS2
(M+H) = 323.9414. Found = 323.9409.
[5] Nogueira CW, Zeni G, Rocha JB. Organoselenium and
organotellurium compounds: toxicology and pharmacology.
Chem Rev. 2004 Dec;104(12):6255–85.
2-Phenyl-5-((phenylselanyl)thio)-1,3,4-oxadiazole
(5b) (Table 3, Entry 2): Yellow liquid, Yield 160 mg (70%).
1H-NMR (500MHz, CDCl3): δ 7.90 (d, 1H, J = 7.5 Hz), 7.20-
7.61 (m, 9H). 13C-NMR (75MHz, CDCl3): δ 133.2, 132.0, 131.4,
129.5, 129.1, 127.6, 126.8. IR(neat): 2919, 2851, 1781, 1726,
1609, 1578, 1576, 1549, 1465, 1349, 1286, 1219, 1170, 1066,
1023, 956, 772, 689 cm-1. MS (ESI): 335 (M+H). HR-MS:
Calculated for C14H10N2OSSe (M+H) = 335.1021. Found =
335.1017.
1-Phenyl-5-((phenylselanyl)thio)-1H-tetrazole (5c)
(Table 3, Entry 3): Yellow liquid, yield 150 mg (80%).
1H-NMR (500MHz, CDCl3): δ 7.70 (d, 1H, J = 7.5 Hz), 7.60-7.20
(m, 9H). 13C-NMR (75MHz, CDCl3): δ 153.2, 150.9, 149.9, 149.2,
149.1, 149.0, 148.6 147.1, 144.0. IR (neat): 3019, 1710, 1661,
1628, 1549, 1515, 1214, 742, 667, 627 cm-1. MS (ESI): 334 (M+H).
HR-MS: Calculated for C13H10N4SSe (M+H) = 334.9864;
Found (M+H) = 334.9860.
[6] Nogueira CW, Quinhones EB, Jung EA, Zeni G, Rocha JB.
Anti-inflammatory and antinociceptive activity of diphenyl
diselenide. Inflamm Res. 2003 Feb;52(2):56–63.
[7] Pavin NF, Donato F, Cibin FW, Jesse CR, Schneider PH, de Salles
HD, et al. Antinociceptive and anti-hypernociceptive effects
of Se-phenyl thiazolidine-4-carboselenoate in mice. Eur J
Pharmacol. 2011 Oct;668(1-2):169–76.
[8] Martínez-Ramos F, Salgado-Zamora H, Campos-Aldrete ME,
Melendez-Camargo E, Márquez-Flores Y, Soriano-García M.
Synthesis and anti-inflammatory activity evaluation
of unsymmetrical selenides. Eur J Med Chem. 2008
Jul;43(7):1432–7.
[9] Sancineto L, Piccioni M, De Marco S, Pagiotti R, Nascimento V,
Braga AL, et al. Diphenyl diselenide derivatives inhibit
microbial biofilm formation involved in wound infection. BMC
Microbiol. 2016 Sep;16(1):220–30.
[10] Álvarez-Pérez M, Ali W, Marć MA, Handzlik J, Domínguez-
Álvarez E. Selenides and Diselenides: A Review of Their
Anticancer and Chemopreventive Activity. Molecules. 2018
Mar;23(3):628–47.
[11] Almeida GM, Rafique J, Saba S, Siminski T, Mota NS, Filho
DW, et al. Novel selenylated imidazo[1,2-a]pyridines for
breast cancer chemotherapy: inhibition of cell proliferation
by Akt-mediated regulation, DNA cleavage and apoptosis.
Biochem Biophys Res Commun. 2018 Sep;503(3):1291–7.
[12] Pinton S, da Rocha JT, Gai BM, Prigol M, da Rosa LV, Nogueira
CW. Neuroprotector effect of p,p′-methoxyl-diphenyl diselenide
in a model of sporadic dementia of Alzheimer’s type in mice:
Supporting Information:ꢀCopies of 1H and 13C NMR
spectra are available.
Acknowledgements:ꢀORGIN program (CSIR) and CSIR
(New Delhi) is gratefully acknowledged for awarding the
fellowship to G. B and VN.